FDA to Discuss Ban on Menthol in Tobacco Products

Dec.30.2022
FDA to Discuss Ban on Menthol in Tobacco Products
FDA to hold workshop on banning menthol flavor in tobacco products on January 12, 2023.

On January 12, 2023, the US Food and Drug Administration (FDA) will hold a workshop on the ban of flavored tobacco products, specifically regarding the use of menthol as a flavoring in tobacco products. The proposed tobacco product standard is to "prohibit the use of menthol as a characterizing flavor in cigarettes and cigars on a scientific basis," marking the first tobacco-related workshop of 2023.


The FDA presentation will provide scientific evidence to inform the development of these proposed regulations and explain the highly impactful scientific assessments used by the FDA to review them.


Bridget Ambrose, the Director of Population Health Science at the FDA's Center for Tobacco Products (CTP) Office of Science (OS), will be delivering a speech. Ambrose has over 20 years of experience in tobacco control and regulatory science, and has expertise in longitudinal analyses of tobacco use.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Thailand Seizes Over 42,000 Illegal Vapes Worth USD 340,000
Thailand Seizes Over 42,000 Illegal Vapes Worth USD 340,000
Thai authorities announced the seizure of more than 42,000 smuggled vapes worth approximately THB 10.87 million (USD 340,000).
Dec.12 by 2FIRSTS.ai
COP11 Concludes with Major Decisions on Global Tobacco Control
COP11 Concludes with Major Decisions on Global Tobacco Control
The Eleventh Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on November 22, with 160 Parties adopting major decisions on tobacco and nicotine regulation, environmental protection, sustainable financing, and tobacco industry liability. A landmark decision mandates a complete ban on the use and sale of tobacco and all novel nicotine products across all UN premises worldwide.
Nov.24 by 2FIRSTS.ai
Special Report | Belarus to centralize vaping market under state supervision
Special Report | Belarus to centralize vaping market under state supervision
Belarus is preparing to overhaul its vaping market under tight state control — from monopolizing imports to banning online sales and restricting retail licenses. Officials say nearly 77% of the disposable e-cigarette market is supplied illegally, prompting sweeping regulatory measures that have already sparked strong pushback from consumers and vape retailers.
Dec.03
Special Report| Vuse Gains as U.S. Cracks Down on Illegal Vapes, But a $590 Million China Export Shadow Looms
Special Report| Vuse Gains as U.S. Cracks Down on Illegal Vapes, But a $590 Million China Export Shadow Looms
The payoff is here: BAT’s Vuse has seized a rare regulatory vacuum to reverse its U.S. slide, capitalizing on a crackdown that seemingly compressed the illicit market to 54%. But the victory is fragile. A record $590 million export shock in October signals the gray market is striking back—pitting a fleeting compliance dividend against a massive inventory wall.
BAT
Dec.09
Ispire and IKE Tech Welcome FDA Enforcement Boost, Highlight Need for Tech-Based Controls
Ispire and IKE Tech Welcome FDA Enforcement Boost, Highlight Need for Tech-Based Controls
Ispire Technology and IKE Tech issued statements after the U.S. FDA received Congressional funding and directives to strengthen enforcement against illicit vaping products. The companies emphasized updated guidance, multi-agency coordination and the role of blockchain and age-verification technologies in preventing illegal imports and protecting youth.
Nov.20
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai